Canadian Hypertension Guidelines Expressly Warn Against ARB/ACE-Inhibitor Combo--Should Others Follow?
This is a discussion on Canadian Hypertension Guidelines Expressly Warn Against ARB/ACE-Inhibitor Combo--Should Others Follow? within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; One expert in the US has published a viewpoint saying that dual RAS blockade is "dead until further notice.&...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
02-03-2009, 06:02 PM
|
|||
|
|||
Canadian Hypertension Guidelines Expressly Warn Against ARB/ACE-Inhibitor Combo--Should Others Follow?
One expert in the US has published a viewpoint saying that dual RAS blockade is "dead until further notice." The Canadian Hypertension Education Program has issued a guideline alert warning against the combo, but for now the AHA says it has no intention of doing so.
Heartwire More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Follow-up to the March 27, 2008, Communication about the Ongoing Safety Review of Montelukast (Singulair) | industry_news | FDA News | 0 | 01-13-2009 03:42 PM |
| Follow-up to the January 25, 2008 Early Communication about an Ongoing Data Review for Ezetimibe/Simvastatin (marketed a | industry_news | FDA News | 0 | 01-08-2009 04:32 PM |
| HIV-1 Integrase Inhibitor Effective for Resistant HIV-1 | industry_news | Other Clinical Pharmacy News | 0 | 07-24-2008 04:41 PM |
| Biotech's next big opportunity: Follow-ons? | industry_news | Biotechnology News | 0 | 04-24-2008 03:31 PM |
| Cholinesterase inhibitor use in children with autism | participant3 | Managed Care Issues for Oral Drugs | 1 | 02-27-2008 04:49 PM |
© 2008 DrugManagementForum™ powered by |
 |